Cargando…
Drug-Induced Liver Injury: Pattern Recognition and Future Directions
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause of acute liver failure in most countries. An aging population that uses more medications, a constant influx of newly developed drugs and a growing risk from unfamiliar herbal and dietary supplements wi...
Autores principales: | Haque, Tanvir, Sasatomi, Eizaburo, Hayashi, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694731/ https://www.ncbi.nlm.nih.gov/pubmed/26696029 http://dx.doi.org/10.5009/gnl15114 |
Ejemplares similares
-
Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis
por: Stevenson, Heather L., et al.
Publicado: (2017) -
Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?
por: Johnson, Steven M., et al.
Publicado: (2020) -
Drug-induced liver injury: present and future
por: Suk, Ki Tae, et al.
Publicado: (2012) -
Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States
por: Hayashi, Paul H.
Publicado: (2016) -
Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
por: Weber, Sabine, et al.
Publicado: (2022)